다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The journal of nutrition, health & aging, v.16 no.4, 2012년, pp.339 - 345
Vellas, B. , Hampel, H. , Rouge-Bugat, M.E. , Grundman, M. , Andrieu, S. , Abu-Shakra, S. , Bateman, R. , Berman, R. , Black, R. , Carrillo, M. , Donohue, M. , Mintun, M. , Morris, J. , Petersen, R. , Thomas, R.G. , Suhy, J. , Schneider, L. , Seely, L. , Tariot, P. , Touchon, J. , Weiner, M. , Sampaio, C. , Aisen, P.
AI-Helper
While we may not be able to find a cure for Alzheimer's disease (AD) in the near future, several drugs presently in trials have shown promise as possible modifiers of disease progression. However, we may not be able to demonstrate efficacy due to issues of recruitment, retention, site-to-site v...
Ann Neurol Schor 69 237 2011 10.1002/ana.22365 What the halted phase III gamma-secretase inhibitor trial may (or may not) be telling us
Alzheimers Dement Mattsson 7 386 2011 10.1016/j.jalz.2011.05.2243 The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
Lancet Neurol Dubois 6 734 2007 10.1016/S1474-4422(07)70178-3 Research criteria for the diagnosis of Alzheimers disease: revising the N1NCDS ADRDA criteria
Lancet Neurol Dubois 9 1118 2010 10.1016/S1474-4422(10)70223-4 Revising the definition of Alzheimer’s disease: anew lexicon
Alzheimers Dement Albert 7 270 2011 10.1016/j.jalz.2011.03.008 The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Alzheimers Dement Jack 7 257 2011 10.1016/j.jalz.2011.03.004 Introduction to revised criteria for the diagnosis of Alzheimer’s disease: National Institute on Aging and the Alzheimer’s Association workgroup
Alzheimers Dement McKhann 7 263 2011 10.1016/j.jalz.2011.03.005 The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup
Alzheimers Dement Sperling 7 280 2011 10.1016/j.jalz.2011.03.003 Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup
Neurology Kantarci 78 232 2012 10.1212/WNL.0b013e31824365ab APOE modifies the association between Abeta load and cognition in cognitively normal older adults
10.1007/s12603-012-0011-6 Schneider LS: Recruitment methods for United States Alzheimer disease prevention trials. J Nutr Health Aging. In Press (2012).
Alzheimers Dement Sabbagh 5 128 2009 10.1016/j.jalz.2009.01.018 Commentary on “a roadmap for the prevention of dementia II. Leon Thai Symposium 2008.” A national registry to identify a cohort for Alzheimer’s disease prevention studies
J Nutr Health Aging Andrieu 15 562 2011 10.1007/s12603-011-0142-1 IAGG workshop: health promotion program on prevention of late onset dementia
Epidemiol Rev Coley 30 35 2008 10.1093/epirev/mxn010 Dementia prevention: methodological explanations for inconsistent results
Neurology Salloway 73 2061 2009 10.1212/WNL.0b013e3181c67808 A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Nat Rev Drug Discov Hampel 9 560 2010 10.1038/nrd3115 Biomarkers for Alzheimers disease: academic, industry and regulatory perspectives
J Alzheimers Dis van Rossum 20 881 2010 10.3233/JAD-2010-091606 Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design
Prog Neurobiol Prvulovic 95 517 2011 10.1016/j.pneurobio.2011.11.009 Ethical considerations of biomarker use in neurodegenerative diseases-A case study of Alzheimer’s disease
Nat Rev Neurol Blennow 6 131 2010 10.1038/nrneurol.2010.4 Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Trends Neurosci Ewers 34 430 2011 10.1016/j.tins.2011.05.005 Neuroimaging markers for the prediction and early diagnosis of Alzheimer’s disease dementia
Prog Neurobiol Hampel 95 579 2011 10.1016/j.pneurobio.2010.11.005 Biomarkers for Alzheimer’s disease therapeutic trials
Alzheimers Dement Sperling 7 367 2011 10.1016/j.jalz.2011.05.2351 Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup
Donohue MC, Aisen P (2012) Profile models versus slope models for assessing longitudinal change in Alzheimer’s disease clinical trials. J Nutr Health Aging. In Press.
European Medicines Agency CHMP (2010) Guidelines on Missing Data in Confirmatory Clinical Trials. London, United Kingdom.
2010 The Prevention and Treatment of Missing Data in Clinical Trials
Arch Neurol Schneider 68 58 2011 10.1001/archneurol.2010.343 Treatment with Cholinesterase inhibitors and memantine of patients in the Alzheimer’s Disease Neuroimaging Initiative
10.1007/s12603-012-0021-4 Hampel H, Prvulovic D (2012) Are biomarkers harmful to recruitment and retention in Alzheimer’s disease clinical trials? An international perspective. J Nutr Health Aging. In Press.
JAMA Snitz 302 2663 2009 10.1001/jama.2009.1913 Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial
Alzheimers Dement Meinert 5 93 2009 10.1016/j.jalz.2008.09.004 Alzheimer’s Disease Antiinflammatory Prevention Trial: design, methods, and baseline results
Neurology Vellas 67 S6 2006 10.1212/WNL.67.9_suppl_3.S6 The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint
The Lancet 360 7 2002 10.1016/S0140-6736(02)09327-3 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo controlled trial
JAMA Shumaker 289 2651 2003 10.1001/jama.289.20.2651 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial
Stat Med Kryscio 23 285 2004 10.1002/sim.1716 Designing a large prevention trial: statistical issues
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.